GC-MS Reveals the Metabolic Cost of Making Cytochrome b5 in E. coli

Recombinant protein production underpins much of modern biotechnology, from therapeutic enzymes and monoclonal antibodies to industrial enzymes used in food and cosmetics. Yet coaxing a bacterial cell to manufacture a foreign protein is never free. Every extra molecule of product draws on the host’s energy reserves, precursors, and cofactors, and the cell’s metabolic network must bend to accommodate the demand. A new study published in the journal Metabolomics has now mapped, in fine biochemical detail, exactly what happens inside Escherichia coli when it is forced to produce a mammalian protein, revealing a coordinated reprogramming of central metabolism that could guide the design of more efficient production strains.

The research, led by Thanyaporn Tengsuttiwat, Howbeer Muhamadali, and Royston Goodacre at the University of Liverpool, together with colleagues at Aberystwyth University and Thailand’s National Center for Genetic Engineering and Biotechnology, focused on a classic model system: seven strains of E. coli N4830-1 engineered to produce cytochrome b5, a small heme-containing protein that turns the bacteria visibly pink when expressed. The strains, designated N0 through N6, carry between zero and six copies of the cyt b5 gene on plasmids under the control of a temperature-sensitive lambda PL promoter. At 30 degrees Celsius the promoter remains silent, but shifting the culture to 38.5 degrees Celsius releases the lambda cI857 repressor and switches on production synchronously across the entire population, without the need for chemical inducers.

To interrogate the metabolic consequences of this induction, the team employed gas chromatography coupled with mass spectrometry, or GC-MS, an analytical technique prized for its sensitivity and its coverage of central carbon and nitrogen metabolism. Bacterial cultures were rapidly quenched with pre-chilled methanol to freeze metabolism in place, intracellular metabolites were extracted through freeze-thaw cycling, and the dried extracts were chemically derivatised to make them volatile enough for GC analysis. The instrument, an Agilent 8890 GC fitted with a quadrupole time-of-flight mass spectrometer, generated raw data on 861 metabolic features, which the researchers rigorously curated down to 340 high-quality features using internal standards, pooled quality controls, and strict filtering criteria based on reproducibility and chromatographic peak shape.

The statistical treatment was equally careful. Principal component analysis, a chemometric method that compresses thousands of measurements into a few interpretable axes, cleanly separated induced from non-induced cultures along the first principal component, which alone explained more than 41 percent of the total variance. A semi-supervised extension called principal component discriminant function analysis then revealed something striking: among the induced samples, the metabolic profiles arranged themselves along a trajectory that tracked the gene copy number, from strain N0 to N6, even though the algorithm had never been told the ordering. The trend was not perfectly linear, however, hinting that regulatory constraints and adaptive stress responses, rather than gene dosage alone, shape the metabolic landscape during production.

Mapping the significant metabolites onto known E. coli pathways exposed the energetic heart of the burden. Metabolites of the tricarboxylic acid cycle, including citrate, isocitrate, fumarate, and oxaloacetate, together with glycolytic intermediates such as pyruvate, lactate, and 3-phosphoglycerate, were all significantly depleted in the cytochrome b5-producing strains. The pentose phosphate pathway and the glyoxylate shunt showed parallel depletions. The authors interpret this pattern as evidence of a substantially elevated demand for ATP, the universal cellular energy currency, consistent with earlier reports that glycolytic flux in E. coli is tightly controlled by the cell’s energy requirements and that recombinant protein synthesis drives increased flux through energy-generating pathways.

One particularly telling observation involved nicotinamide, a precursor of the essential redox cofactor NAD. Its concentration declined progressively with increasing cyt b5 gene copy number across strains N0 to N4, and tryptophan, from which nicotinamide can be biosynthesised, also shifted significantly between conditions. This suggests that the cofactor supply system itself was being drawn upon to support the redox demands of recombinant expression, providing a potential metabolic bottleneck that strain engineers could target.

The study also documented how the bacteria remodel their membranes and cell walls in response to the double insult of heat induction and protein overproduction. Glycerol, glycerol-3-phosphate, ethanolamine, and O-phosphoethanolamine, all intermediates in phospholipid biosynthesis, changed significantly, as did several unsaturated fatty acids including oleic acid, elaidic acid, and palmitoleic acid, which decreased under induction. N-acetylglucosamine, a building block of the bacterial cell wall, was markedly reduced. These changes echo the well-known homeoviscous adaptation by which bacteria adjust membrane lipid composition to maintain fluidity at elevated temperatures, and they indicate that the cell envelope is a major site of metabolic reconfiguration during recombinant production.

Stress responses left equally clear fingerprints. The polyamines putrescine, cadaverine, and spermidine, compounds known to accumulate under heat, osmotic, oxidative, and ultraviolet stress, were all detected, with putrescine declining while cadaverine and its catabolic derivative 5-aminovaleric acid rose under induction. Alterations in purine and pyrimidine metabolites, including hypoxanthine, thymine, 5,6-dihydrouracil, and orotic acid, pointed to impacts on nucleotide biosynthesis, while changes in glutamine, glutamate, serine, and tryptamine reflected pressure on amino acid pools. Because the experimental design included a control strain carrying the plasmid backbone but no cyt b5 gene, the team could partially disentangle the effects of the 8.5-degree temperature shift itself from those of protein production, concluding that heat induction is the dominant driver of metabolic reprogramming, with gene copy number modulating specific features on top of that response.

The authors are candid about the limitations of their untargeted approach. Absolute quantification was not possible, and the absence of a dedicated washing step means some detected compounds may have originated from the nutrient-rich LB medium rather than from endogenous synthesis. They propose that future work combine intracellular metabolic profiling with metabolic footprinting, lipidomics, targeted quantitative assays, adenylate energy charge measurements, and 13C-based fluxomics to fully characterise the burden and pinpoint bottlenecks. Even so, the findings demonstrate that cytochrome b5 production triggers coordinated adjustments across energy metabolism, cell envelope biosynthesis, nucleotide metabolism, and stress responses. As the global recombinant protein market, valued at roughly 3.25 billion US dollars in 2024, is projected to approach 8.66 billion by 2034, understanding these hidden metabolic costs at pathway level offers a practical roadmap for engineering bacterial hosts and culture conditions that deliver more protein per cell, with less waste of the cell’s own precious energy.

Subject of Research: GC-MS metabolic profiling of recombinant cytochrome b5 production and its metabolic burden in E. coli N4830-1

Article Title: Metabolic profiling analysis of cytochrome b5 production in E. coli N4830-1 using GC-MS

Article References: Metabolic profiling analysis of cytochrome b5 production in E. coli N4830-1 using GC-MS. (n.d.). https://doi.org/10.1007/s11306-026-02522-5

Image Credits: AI Generated

DOI: 10.1007/s11306-026-02522-5

Keywords: metabolomics, GC-MS, E. coli, cytochrome b5, recombinant protein production, metabolic burden, TCA cycle, chemometrics, membrane remodeling, stress response, biotechnology, Metabolomics journal